Revagenix, Inc

Revagenix is a precision-therapeutics company specializing in the discovery and development of targeted medicines for serious chronic diseases, with a primary focus on respiratory conditions such as non-cystic fibrosis bronchiectasis. Leveraging a biology-driven, first-principles approach, the company engineers therapies optimized for disease biology, patient need, and real-world delivery requirements. The team brings experience spanning the entire drug lifecycle from discovery through commercialization and collaborates closely with public and private partners to accelerate advancement from early-stage science to clinical development.